Amneal Pharmaceuticals Inc. Earnings

Amneal Pharmaceuticals Inc.’s revenue jumped 11.47% since last year same period to $814.32Mn in the Q4 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 3.8% jump in its revenue since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit jumped 212.85% since last year same period to $35.08Mn in the Q4 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 1380.62% jump in its net profits since last 3-months.

Amneal Pharmaceuticals Inc.’s net profit margin jumped 201.24% since last year same period to 4.31% in the Q4 2025. On a quarterly growth basis, Amneal Pharmaceuticals Inc. has generated 1326.43% jump in its net profit margins since last 3-months.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.19 - a 7.53% jump from last quarter’s estimates.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) estimates for the current year stand at 0.19.

Amneal Pharmaceuticals Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Amneal Pharmaceuticals Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.